Daily Subcutaneous injections of Relaxin is a therapy for heart failure with preserved ejection fraction
Year: 2024
Type: article
Source: European Heart Journal
Authors: G Salama, T B D Dschietzig, B W Gabris-Weber, B M Mcmahon, A M Mauro, G R Romero
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4403818276
